Correction: Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial

Correction: Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial

Saved in:

Bibliographic Details
Main Authors:	Xi Zhang, Ke Chen, Hanglian Lan, Haixia Chen, Hua Chen, Ping Yang, Nianyang He, Weilian Hung, Zaozhong Zeng, Changqi Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Nutrition
Subjects:	probiotics short chain fatty acids children gut microbiota upper respiratory tract infection
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2025.1661669/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial
by: Xi Zhang, et al.
Published: (2025-06-01)

Clinical effects of Bifidobacterium Longum Subsp. Infantis YLGB-1496 on children with respiratory symptoms
by: Pin Li, et al.
Published: (2025-02-01)

Indole Derivatives Biosynthesis in Bifidobacterium longum subsp. infantis and the Tryptophan Substrate Availability
by: Shi‐Min Zhang, et al.
Published: (2025-06-01)

Protective effects of Bifidobacterium longum subsp. longum BL21 against cyclophosphamide-induced reproductive dysfunction in zebrafish
by: Yao Dong, et al.
Published: (2025-04-01)

Uptake of fucosylated type I human milk oligosaccharide blocks by Bifidobacterium longum subsp. infantis
by: Morten Ejby Hansen, et al.
Published: (2025-08-01)

Selection and in vitro Probiotic Properties of Bifidobacterium longum subsp. longum with Anti-diabetic Activity from the Intestinal Tract of Chinese Tajik Children
by: LI Si, AN Meiling, LI Longlong, ZHANG Ruirui, SUN Hailong, NI Yongqing
Published: (2025-05-01)

Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01)

Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01)

Antibiotic Resistance in <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> and <i>Bifidobacterium longum</i>: Definition of Sensitivity/Resistance Profiles at the Species Level
by: Mario Terlizzi, et al.
Published: (2025-07-01)

Stress Resistance of Biofilm-type Bifidobacterium longum subsp. longum and Its Effect on Intestinal Microbiota
by: Shuang YAN, et al.
Published: (2025-08-01)

Bifidobacterium longum subsp. infantis CCFM1269 promotes intestinal barrier and release of IFN-β through TLR4-TRIF dependent way in growing mice
by: Mengfan Ding, et al.
Published: (2025-01-01)

Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Meina Li, et al.
Published: (2025-08-01)

Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01)

Propionibacterium freudenreichii co-inoculation enhances Bifidobacterium longum subsp. longum BB536 growth and metabolite content in soy whey
by: Ricco Tindjau, et al.
Published: (2025-09-01)

Effect of inulin on the growth and survival of Bifidobacterium longum BB536 in fermented goat’s and cow’s milk
by: Marina Šimunek, et al.
Published: (2009-09-01)

Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice
by: Xihua Yu, et al.
Published: (2025-07-01)

Bifidobacterium longum subsp. longum dipro-O: a potential therapeutic agent for ameliorating metabolic disorders in high-fat diet-induced obesity mouse model
by: Ning Xu, et al.
Published: (2025-06-01)

<i>Lactobacillus helveticus R0052</i> and <i>Bifidobacterium longum R0175</i> Supplementation: An Exploratory, Randomized, Placebo-Controlled Trial of Endocannabinoid and Inflammatory Responses in Female Dancers
by: Jakub Wiącek, et al.
Published: (2025-05-01)

Understanding the probiotic health benefits of Bifidobacterium animalis subsp. lactis, BB-12™
by: Fergus W. J. Collins, et al.
Published: (2025-07-01)

The impact of ingestion of Bifidobacterium longum NCC3001 on perinatal anxiety and depressive symptoms: a randomized controlled trial
by: Lisa R. Fries, et al.
Published: (2025-04-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Development of healthy whey drink with Lactobacillus rhamnosus, Bifidobacterium bifidum and Propionibacterium freudenreichii subsp. shermanii
by: T.K. Maity, et al.
Published: (2008-12-01)

Some Properties of Probiotic Yoghurt Produced for Babies by Adding Fruit Puree, Containing B. infantis, B. bifidum, B. longum, L. paracasei
by: Didem Sözeri Atik, et al.
Published: (2021-11-01)

Probiotic properties of an indigenous strain composition of <i>Bifidobacterium bifidum</i> ICIS-310 and <i>Bifidobacterium longum</i> ICIS-505 <i>in vitro</i>
by: N. B. Perunova, et al.
Published: (2025-06-01)

Role of Bifidobacterium animalis subsp. lactis BB-12 in mice with acute pancreatitis
by: Bingbing Du, et al.
Published: (2025-04-01)

Interactions between the human milk oligosaccharide 2′-fucosyllactose and Bifidobacterium longum subspecies infantis in influencing systemic immune development and function in piglets
by: Victoria C. Daniels, et al.
Published: (2024-10-01)

Probiotic Bifidobacterium longum Subsp. longum 51A Protects Mice from Genotoxic and Metabolic Alterations Induced by Subchronic Exposure to a Low-Dose Pesticide Cocktail
by: Mirna Maciel d’Auriol Souza, et al.
Published: (2025-08-01)

Effects of phototherapy combined with Lactobacillus salivarius AP-32 or Bifidobacterium animalis subsp. lactis CP-9 on improving neonatal jaundice and gut microbiome health: a randomized double-blind clinical study
by: Ming-Luen Tsai, et al.
Published: (2025-05-01)

Scientific Opinion on the substantiation of a health claim related to a combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) and decreasing potentially pathogenic intestinal microorganisms pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2009-12-01)

A double blinded randomized placebo trial of Bifidobacterium animalis subsp. lactis BLa80 on sleep quality and gut microbiota in healthy adults
by: Yinhua Liu, et al.
Published: (2025-04-01)

Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
by: Shunyu Yao, et al.
Published: (2021-01-01)

Comparative in silico analyses between Lactiplantibacillus plantarum and Bifidobacterium longum concerning probiotic properties, anti-lipidemic, and anti-diabetic in vitro activities
by: Asmaa Negm El-Dein, et al.
Published: (2025-06-01)

Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11
by: Alexander Bertuccioli, et al.
Published: (2025-05-01)

The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial
by: Ida Marie Bruun Grønbæk, et al.
Published: (2025-04-01)

Effect of Bifidobacterium animalis subsp. lactis Langg JZ-08 on lipid metabolism in individuals with obesity and dyslipidemia: A randomised, double-blind, and placebo-controlled trial
by: Xiaokang Niu, et al.
Published: (2025-06-01)

Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
by: Zhifeng Fang, et al.
Published: (2022-12-01)

Bifidobacterium animalis subsp. lactis A6 alleviates perennial allergic rhinitis in adults by inhibiting serum total IgE and IL‐13: A randomized, double‐blind, placebo‐controlled trial
by: Langrun Wang, et al.
Published: (2025-06-01)

Effect of Bifidobacterium Probiotic in the Treatment of Giardiasis Infection in Mice
by: Israa Mohammad Abd AL-Khaliq
Published: (2019-12-01)

Determination of Probiotic Viability in Yoghurts Produced with Acid Adapted Lactobacillus acidophilus ATCC 4356 and Bifidobacterium bifidum ATCC 11863 During Refrigerated Storage
by: Şehriban Oğuz, et al.
Published: (2023-12-01)

Bifidobacterium animalis subsp. Lactis BX-BC08 modulates gut microbiota and secretes alpha-Ketoglutaric acid to alleviate MC903-induced atopic dermatitis
by: Jiamin Zhao, et al.
Published: (2025-07-01)